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Abstract
BACKGROUND: Oxidative stress in type 2 diabetes mellitus (T2D) causes insulin resistance and disordered insulin 
secretion. Pathomechanisms of T2D consist of dysfunctional pancreatic β-cell and insulin resistance caused by free 
radical (reactive oxygen species and reactive nitrogen species) that produced from the glucose metabolism pathway. 
Insulin resistance can be measured using the homeostatic model assessment of insulin resistance (HOMA-IR). 
Oxidative stress can measure through the activities of malondialdehyde (MDA) and superoxide dismutase (SOD).
AIM: This research aims to study the potential of chayote (Sechium edule Jacq. Swartz) to be used as 
antihyperglycemic in T2D.
MATERIALS AND METHODS: This research was conducted with a post-test randomized controlled group design. 
Eleven groups with four male rats each were used. Normal untreated rats were treated under ad libitum feeding and 
drinking condition. Meanwhile, the rat models were induced with the combination of 45 mg/kg b.w. streptozotocin, 
110 mg/kg b.w. nicotinamide, 40.5 mg/kg b.w. metformin, high-fat diet, and/or chayote extract. The chayote extract 
was orally administered to the rat in the form of ethanol extract and/or ethyl acetate fraction, with three dosages of 
45 mg/kg b.w., 100 mg/kg b.w., and 150 mg/kg b.w. for each extract type. The body weight, glucose level, insulin 
level, MDA, and SOD activities were measured. The HOMA-IR was used.
RESULTS: The lowest body weight of the rat model in week 0 was 145 ± 25.31, founded in Group H that was 
treated with ethyl acetate fraction of chayote extract (45 mg/kg b.w.). The lowest blood sugar level in the group with 
2 h glucose load was 112.5 ± 27.00 on average, found in Group G that was treated with chayote ethanolic extract 
(150 mg/kg b.w.). The highest SOD in the group treated with chayote extract was 1.27 ± 0.20, founded in Group 
H treated with ethyl acetate 45 mg/kg b.w. The lowest level of MDA was 0.86 ± 0.70 in Group H treated with ethyl 
acetate 45 mg/kg b.w. The lowest fasting blood sugar spectrophotometer level was 150.54 ± 17.24 mg/dl in Group K 
with metformin treatment, followed by 155.16 ± 31.92 mg/dl in Group K treated 45 mg/kg b.w. ethanol treatment. The 
highest insulin level was 6.14 ± 0.71, founded in Group F that was treated with chayote ethanolic extract 100 mg/kg 
b.w. The lowest measurement of HOMA-IR was 0.16 ± 0.80 in Group E treated with ethanol extract of chayote 
45 mg/kg b.w.
CONCLUSION: Ethanol extract and fractionation of chayote work as an antioxidant and anti-insulin resistance.
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Introduction
Chronic hyperglycemia induces the increase 
of oxidative stress due to the uncontrolled reactive 
oxygen species (ROS) and reactive nitrogen species. 
This condition plays an important role in tissue 
destruction of the patients of Type 1 diabetes mellitus 
(T1D) and Type 2 diabetes mellitus (T2D). There 
will be damage in pancreatic β-cell for T1D and 
insulin resistance or disordered insulin secretion for 
T2D patients [1], [2], [3]. To measure the ineffective 
performance of insulin as a result of insulin resistance, 
as well as to check the function of pancreatic ß-cell, 
homeostatic model assessment of insulin resistance 
(HOMA-IR) can be used as a measurement [4], [5]. 
Two main pathophysiology mechanisms of HOMA-IR 
are dysfunctional pancreatic ß-cell and insulin 
resistance [4], [6], [7], [8]. These two mechanisms are 
underlined by the existence of oxidative stress, the 
increase of ROS product by hexosamine pathway, 
advanced glycation end-products, fat acid free, and leptin 
which produces ROS. The increasing of free radicals will 
stimulate the formation of adipokines, cytokines, and 
prostanoids which then cause insulin resistance [3].
The damage of pancreatic β-cell can be 
modeled in a hyperglycemic animal model, using 
streptozotocin (STZ) and nicotinamide (NA) to induce 
hyperglycemia. STZ may damage the pancreatic β-cell, 
however, the NA application may protect pancreatic 
β-cell from further damage caused by the STZ effect. 
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NA injection after giving STZ with time interval may give 
partial protection to the ß-cell cytotoxic effect. Effective 
protection is attained if NA is injected 2 h after giving 
the STZ, and less effective protection if the interval is 
longer. STZ was carried to pancreatic β-cell through 
glucose transporter (GLUT2), which may cause DNA 
damage through the raising of poly(ADP-ribose) 
polymerase (PARP-1) activities [9], [10].
The abnormality caused by hyperglycemia 
can be controlled through the oral treatment of 
antihyperglycemic, which can alternatively be 
utilized from herbal medicine with anti-hypoglycemia 
potential and antioxidant activities. According to 
Siahaan et al. [11], the flavonoid content in the plant, as 
in chayote (Sechium edule Jacq. Swartz), can decrease 
the blood sugar level (BSL) and increase the antioxidant 
level in diabetic mice. There was also a difference in 
the diameter of the pancreatic β-cell between chayote-
treated mice and non-treated mice [11], [12].
Materials and Methods
Study site
This study was undertaken at the Biomedical 
Laboratory, Faculty of Medicine, University of North 
Sumatra for a year.
Collection and preparation of plant 
materials
Chayote was collected with purposive sampling 
method from the yards of a citizen of Sidamanik district, 
Sumatera Utara, Indonesia.
Experimental design
This research is a laboratory experimental 
research conducted with a post-test randomized 
controlled group design using hyperglycemic white 
male Wistar rat. The design of this research has 
allowed the measurement of the effect of treatment 
to the experimental group by comparing the treated 
group with the untreated/control group. Nonetheless, 
the design does not allow the measurement of the 
level of the change caused by the treatment, as 
there was no initial measurement at the beginning 
of the research. The treatments to all samples were 
conducted at the same time and the post-test only 
control group design was conducted after a certain 
time. In this design, the sample was obtained 
using simple random sampling method. Therefore, 
the animal model, location of experiment, and the 
materials were homogenous.
Experimental groups
The animal models used in this research are 
healthy white male Wistar rats aged 2.5–3 months 
old, with a body weight between 150 and 220 g. 
The rats body weight was measured in week 0 to 
determine if the rats used to fit into the inclusion 
criteria specified. The selection of rat as a model 
was based on its genetic similarity with human and 
their ability to adapt to the laboratory environment. 
The number of the sample used was determined 
using randomization method for animal experiment 
by Federer equation: (n-1) (t-1) ≥ 15, where t is 
the number of treatments while n is the number of 
animals per treatment. Eleven groups with four male 
rats each were then used in this research, with 44 
male rats as a sample in total.
The following 11 groups of rats were used 
for the experiments, Group A: Normal untreated rats 
under ad libitum feeding and drinking condition (the 
negative control), Group B: Rats were administered 
with STZ 45 mg/kg b.w. + NA 110 mg/kg b.w. + 
high-fat diet (HFD) (the positive control), Group C: 
Rats were administered with STZ 45 mg/kg b.w. + 
HFD (the positive control), Group D: Rats were 
administered with NA 110 mg/kg b.w. + HFD (the 
positive control), Group E: Rats were administered 
with STZ 45 mg/kg b.w. + NA 110 mg/kg b.w. + HFD 
+ chayote ethanol extract 45 mg/kg b.w., Group F: 
Rats were administered with STZ 45 mg/kg b.w. + 
NA 110 mg/kg b.w. + HFD + chayote ethanol extract 
100 mg/kg b.w., Group G: Rats were administered 
with STZ 45 mg/Kg b.w. + NA 110 mg/kg b.w. + HFD 
+ chayote ethanol extract 150 mg/kg b.w., Group H: 
Rats were administered with STZ 45 mg/kg b.w. + 
NA 110 mg/kg b.w. + HFD + ethyl acetate fraction of 
chayote extract 45 mg/kg b.w., Group I: Rats were 
administered with STZ 45 mg/kg b.w. + NA 110 mg/kg 
b.w. + HFD + ethyl acetate fraction of chayote extract 
100 mg/kg b.w., Group J: Rats were administered 
with STZ 45 mg/kg b.w. + NA 110 mg/kg b.w. + HFD 
+ ethyl acetate fraction of chayote extract 150 mg/kg 
b.w., and Group K: Rats were administered with STZ 
45 mg/kg b.w. + NA 110 mg/kg b.w. + HFD + metformin 
40.5 mg/kg b.w.
Preparation of chayote ethanolic extracts 
The chayote ethanolic extract was obtained 
through the maceration process using ethanol 80%. 
About 10 simplicia and 75 parts of the solvent were 
kept in a stoppered container for 5 days with frequent 
agitation until the soluble matter is dissolved. The 
liquid phase was separated from the solid material with 
frequent filtration. A sufficient amount of solvent was 
added to solid residue until the liquid collected is 100 
parts. The liquid phase was then moved to another 
tightly stoppered container, was protected from sunlight, 
and placed in cool space for 2 days. The layer of liquid 
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closer to the top of the container was separated from 
the other material with decantation. The concentrated 
ethanolic extract was then resulted using a rotary 
evaporator at 40°C set of temperature.
Preparation of ethyl acetate fraction 
About 20 g of concentrated chayote ethanolic 
extract was mixed with 50 ml of ethanol 96% and 
100 ml aquadest until homogenous. The mixture was 
partitioned in the separator funnel using 100 ml ethyl 
acetate until the liquid phase showed a negative 
response to FeCl3 and ethyl acetate fraction was 
formed. The concentrated ethyl acetate fraction was 
then resulted using a rotary evaporator at 40°C set of 
temperature. 
Hyperglycemia induction
Rats were treated with NA (110 mg/kg b.w.) 
with a 15 min interval to the following intraperitoneal 
injection of 45 mg/kg b.w. cold STZ in NaCl 0.9%. Wistar 
rat is categorically suffered from diabetes mellitus (DM) 
if the level of blood sugar is >250 mg/dl after 72 h of 
induction [13], [14].
Insulin resistance induction with HFD
The formula used is a modification of Listianasari 
et al. [15] formula. The rat was fed with HFD from the 
mixture of egg yolk, coconut oil, and butter. This diet was 
given using a gastric/feeding tube in the amount of 4 ml/
day/rat.
Glucose loading
The rats were fasted and fed with chayote 
extract. The rats were 30 min later loaded with glucose 
75 g (dosage for rats converted to 1.35/200 g b.w). The 
BSL after ½ h, 1 h, 1 ½ h, and 2 h was then measured. 
The rat body weight was measured using a balance 
and BSL was measured with a spectrophotometer. 
The activities of malondialdehyde (MDA), superoxide 
dismutase (SOD), insulin level, and HOMA-IR were 
measured using ELISA. 
Statistical analysis
One-way analysis of variance and Kruskal–
Wallis tests are used to determine if there are statistically 
significant differences between two or more groups of 
treatment in this research. Wilcoxon signed-rank test 
and dependent T-test are used as needed. The level 
of significance was set at p < 0.05. Statistical analyses 
were performed with SPSS, version 18 (SPSS Inc., 
Chicago, IL, USA).
Results
Body weight of rats 
The result showed that the rats model has had 
the proper body weight relevant to the inclusion criteria. 
Body weight of the rats after the diabetic induction and 
body weight after extract treatment in the 2nd–3rd weeks 
are shown in Table 1.
Table 1: Body weight of rats before and after induction and 
extract treatment
Groups Groups
Week 0 Week 1 Week 2 Week 3
A 159.33 ± 12.10 159.67 ± 12.42 162.00 ± 12.77 163.33 ± 12.34
B 178.33 ± 21.36 245.00 ± 77.97 222.67 ± 61.72 203.67 ± 22.50
C 157.67 ± 4.51 222.67 ± 10.02 215.67 ± 5.03 145.33 ± 28.02
D 195.00 ± 33.78 222.67 ± 5.86 201.33 ± 12.06 226.83 ± 66.23
E 164.75 ± 32.35 179.25 ± 27.54 178.50 ± 35.26 176.63 ± 37.24
F 178.25 ± 9.39 199.25 ± 13.55 178.50 ± 11.03 149.50 ± 47.26
G 184.50 ± 14.62 208.75 ± 24.30 207.25 ± 20.45 207.88 ± 22.23
H 145.00 ± 25.31 171.75 ± 34.36 168.00 ± 20.20 153.88 ± 8.76
I 146.25 ± 38.86 141.25 ± 34.48 144.00 ± 39.56 121.25 ± 26.39
J 170.25 ± 41.96 187.00 ± 49.09 186.50 ± 56.25 178.13 ± 57.50
K 170.75 ± 26.91 182.00 ± 23.57 177.50 ± 31.03 182.88 ± 26.05
p-value 0.361** 0.038** 0.105* 0.023*
*Analysis of variance test, ** Kruskal–Wallis test
Based on the measurement of body weight 
(Table 1), the lowest body weight at the beginning of 
the experiment is found in Group H with average weight 
of 145 ± 25.31g, at which rats were treated with STZ 45 
mg/kg b.w., NA 110 mg/kg b.w., HFD, and ethyl acetate 
fraction of chayote extract 45 mg/kg b.w. Meanwhile, 
the highest weight is 195 ± 33.78 g in a group of 
positive control, at which rats were treated with NA 110 
mg/kg b.w. and HFD (Group D). There is no significant 
difference between the groups assessed. 
In the following week after glucose induction, 
the lowest body weight (141.25 ± 34.48 g) in the 1st 
week is found in group of rats that were treated with 
STZ 45 mg/kg b.w., NA 110 mg/kg b.w., HFD, and ethyl 
acetate fraction of chayote extract 100 mg/kg b.w. 
(Group I) while the highest (245 ± 77. 97g) is the positive 
control treated with STZ 45 mg/kg b.w., NA 110 mg/kg 
b.w., and HFD (Group B). No significant difference is 
found among the group in week 1. In week 2, the lowest 
weight is in the group treated with STZ 45 mg/kg b.w., 
NA 110 mg/kg b.w., HFD, and ethyl acetate fraction of 
chayote extract 100 mg/kg b.w. with Group B stays in 
the highest weight among the group. However, there is 
no significant difference among the groups. In week 3, 
a Group I also has the lowest weight among all, while 
Group D that shows the highest weight in week 0 stays 
in the highest position in week 3. p < 0.05 shows that 
there is a difference among groups in this week.
Glucose loading
The result of the glucose load for the rats 
is shown in Table 2. In the 1st week of treatment, the 
highest fasting BSL is found in Group F with an average 
value of 337.50 ± 140.22. The lowest is found in Group 
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A with an average value of 107.33 ± 12.74. There is no 
significant difference between each group.
The highest BSL of the rats loaded with glucose, 
30 min after the treatment, is around 507.75 mg/dl 
founded in Group I while the lowest average value is 
124.33 ± 8.74 mg/dl in Group A. p < 0.05 shows that 
there is the difference in the results of the groups. 
From the measurement 1 h after glucose load, the 
highest BSL is found in Group I (513.75± 172.50 mg/dl) 
while the lowest in Group A (121.33 ± 8.74 mg/dl). p < 
0.05 means that it is significantly different in groups. 
From the measurement 2 h after glucose load, 
the highest is in Group I with the average value of 
BSL 386± 131.71 mg/dl while the lowest group founded 
in Group D with average 104.67± 15.53 mg/dl. From 
the treated group, the average of the lowest BSL is in 
Group K 117.5 ± 29.26. p < 0.01 shows that there is a 
difference in groups. In the 2nd week, the fasting BSL 
of the rats was measured. The highest is in Group C 
(287 mg/dl) while the lowest is Group G (99.75 mg/dl). 
p < 0.05 shows that there is a difference in groups. 
From the measurement 30 min after glucose load, the 
group with the highest BSL is Group H (574.75 mg/dl) 
while the lowest level is in Group A (138 mg/dl). p < 0.01 
means that there is a difference among the groups. 
The highest average of BSL in the measurement 
of 1 h afterload is in Group H with the level of 547.5 ± 
63.00 mg/dl, while the lowest average is in Group A with 
BSL 132.33 ± 4.04. p < 0.001 means that there is a 
difference in groups. The highest average BSL in 1.5 
h is in Group H with 554.25 ± 42.93 mg/dl, while the 
lowest BSL average is in Group A 125.67 ± 9.29 mg/dl. 
p < 0.01 means that there is a difference in groups. From 
the measurement 2 h after glucose load, the checking 
glucose load in 2 h, the highest average value in Group 
H is 499.75 ± 64.46 mg/dl, meanwhile, the lowest 
average is in Group A 118.67±8.08. For the therapy 
group, the lowest BSL average value is in Group G 
112.5± 27.00 mg/dl. p < 0.001 means that there is a 
difference in groups.
If we compare the average of fasting BSL 
between the 1st and 2nd weeks, the highest average 
value is found in week 1 Group F with average value 
337.50± 140.22 mg/dl. Meanwhile, the lowest average 
found in week 2 Group I with average value BSL 101.25 
± 9.54 mg/dl. p < 0.01 means that there is a difference 
between each group.
From the average glucose loaded in 30 min 
after oral glucose load, the lowest BSL is found in the 
treated Group K in week 1 with an average value of 
159.25 ± 33.43 mg/dl. Meanwhile, the highest BSL is 
found in week 2 Group H with average BSL 574.75 ± 
23.17 mg/dl. The p-value shows no difference among 
the groups. However, Group K shows the ability of 
metformin in decreasing the BSL in 30 min after giving 
the glucose, followed by Group F treated with extract 
ethanol 100 mg/kg b.w. with BSL average 218.50 ± 
64.10 mg/dl.Ta
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From the average glucose loaded in 1 h after 
oral glucose load, the group that has the lowest average 
of BSL is also Group K in the 2nd week with an average 
value of 144.25 ± 10.53 mg/dl. The highest average 
value is also in Group F the 2nd week with average BSL 
449 ± 206.28 mg/dl. There is no significant difference 
showed among the groups. However, Group K also 
shows the metformin ability in decreasing BSL in 1 h 
after giving the glucose. It is also followed by Group F 
that was treated with ethanol extract 150 mg/kg b.w. 
with the average BSL 247 ± 18.24 mg/dl.
From the measurement of glucose loaded in 
1.5 h after glucose was given, the highest BSL is in the 
2nd week in Group E with the average value of 554.25 
± 42.93 mg/dl. Meanwhile, the lowest BSL is in the 2nd 
week in Group K 139 ± 12.94, followed by Group G 
for the 2nd week with BSL average 180.75 ± 52 mg/dl. 
p = 0.144 shows the difference among the groups even 
though Groups K and G show the decreasing of clinical 
BSL. 
From the measurement of glucose loaded 
in 2 h after glucose was given, the highest BSL is in 
week 2 in Group H with an average value of 499.75 
± 64.46 mg/dl. Meanwhile, the lowest BSL is found 
in week 2 Group G with an average value of 112.5 ± 
27.00. There is no significant difference showed in 
the 2 h glucose load. The average BSL in Group G is, 
however, clinically lower compared with Group K which 
was treated with metformin. It is even lower than the 
healthy or untreated group.
Measurement of SOD, MDA, BSL, and 
HOMA-AIR
Data of the measurement of SOD, MDA, BSL, 
insulin, and HOMA-IR on the 3rd week are shown in 
Table 3.
Table 3: Data from the analysis of SOD, MDA, BSL, insulin, and 
HOMA-IR
Kelompok SOD MDA BSL Insulin HOMA-IR
A 1.09 ± 0.26 0.689 ± 0.03 186.38 ± 9.70 4.60 ± 1.15 2.12 ± 0.59
B 0.26 ± 0.40 0.79 ± 0.10 215.57 ± 93.18 2.53 ± 2.30 1.69 ± 1.73
C 0.88 ± 0.77 0.89 ± 0.08 413.09 ± 200.63 4.64 ± 3.80 5.87 ± 4.97
D 1.74 ± 0.29 1.11 ± 0.14 276.69 ± 62.34 5.02 ± 4.15 3.79 ± 3.24
E 1.10 ± 0.75 1.59 ± 0.69 155.16 ± 31.92 0.44 ± 0.24 0.16 ± 0.08
F 0.96 ± 0.83 1.40 ± 0.23 167.06 ± 24.34 6.88 ± 1.00 2.83 ± 0.59
G 1.00 ± 0.82 1.19 ± 0.27 187.18 ± 54.57 3.88 ± 2.42 1.68 ± 1.09
H 1.27 ± 0.20 0.86 ± 0.07 229.58 ± 29.93 6.14 ± 0.71 3.44 ± 0.26
I 1.10 ± 0.74 1.00 ± 0.28 163.12 ± 14.62 3.78 ± 2.41 1.46 ± 0.89
J 1.05 ± 1.26 1.50 ± 0.18 278.08 ± 56.74 4.71 ± 3.39 3.32 ± 2.83
K 0.47 ± 0.85 1.24 ± 0.10 150.54 ± 17.24 4.58 ± 3.70 1.75 ± 1.51
P-value 0.525** 0.001* 0.001* 0.188** 0.071*
*Analysis of variance, **Kruskal–Wallis
The highest SOD level in the extract 
treated group is found in Group H with ethyl acetate 
45 mg/kg b.w. treatment. The average level is 1.27 
± 0.20. Meanwhile, the group with the lowest level of 
SOD is Group F which was treated with 100 mg ethanol 
extract/kg b.w. resulted SOD 0.96 ± 0.83. There were 
no significant differences between groups, however, the 
treatment of extracts in Group H was able to increase 
SOD antioxidants higher than other groups.
The highest MDA level is in Group E with 
45 mg/kg b.w. ethanol extract treatment, which is 1.59 ± 
0.69. The lowest is 0.86 ± 0.07 founded in Group H with 
45 mg/kg b.w. ethyl acetate treatment. p = 0.001 means 
that there are significant differences between groups. 
Group H extract can reduce oxidative stress better than 
other groups.
The lowest spectrophotometer of fasting BSL 
is in K group treated with metformin with the level of 
150.54 ± 17.24 mg/dl, followed by Group E treated 
with 45 mg/kg b.w. ethanol, with the level of 155.16 ± 
31.92 mg/dl. p = 0.001 means that there are significant 
differences between groups although the group given 
the extract showed a decrease in BSL, the decrease 
in BSL was better in K group. Metformin has a strong 
ability of hypoglycemia compared to the other groups.
The highest level of insulin is in Group F which 
is 6.14 ± 0.71, the lowest level is in Group E which is 
0.44 ± 0.24 with p = 0.188 it’s mean that there is no 
significant difference between groups, but extract in 
Group F could increase insulin secretion higher than 
with other groups. The highest HOMA-IR in Group H 
is 3.44 ± 0.26, while the lowest is in Group E 0.16 ± 
0.08 with no significant difference between groups. 
Nonetheless, Group E resistance insulin was decreased 
compared to other groups who received extracts or oral 
hypoglycemia.
Discussion
The group treated with extract and fractionation 
has better weight loss in Group I both at days 1, 2, 
and 3, compared with metformin. Fractionation of ethyl 
acetate chayote 100 mg/kg b.w. reduced the mass of 
adipose tissue in the body due to fractionation that 
inhibits mobilization of fat from peripheral adipose 
tissue to plasma [16]. It proves that ethyl acetate fraction 
can inhibit the performance of the pancreatic lipase 
enzyme as an enzyme that plays an important role in fat 
metabolism and fat absorption. Moreover, ethyl acetate 
fraction also plays a role in inhibiting α-glucosidase, thus 
reducing the absorption of carbohydrate [17], [18], [19].
Nevertheless, research conducted by Olaokun 
et al. [19] shows the different results with this study. The 
ethyl acetate fraction used did not reduce weight and 
the mechanism of the failure of ethyl acetate fraction 
in losing weight could not be fully explained. They 
assumed that the fraction ethyl acetate failed to inhibit 
the lipase enzyme while the ethyl acetate fraction was 
able to inhibit α-glucosidase in vitro [19].
Group G had a higher average body weight 
than the other groups in every week. However, the 
increase in body weight did not indicate clinical 
deterioration from the glucose loading. This group 
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had the lowest reduction in a mean of BSL (112.5 ± 
27.00 mg/dl). Meanwhile, Group G which was treated 
with ethanol extract 150 mg/kg b.w. was able to 
withstand weight loss. This condition happened due to 
the presence of saponins which acted like insulin that 
stimulating glucose absorption with Glut4 expression 
raise, contributing in the store of glucose in adipocyte 
cells in the form of glycogen through stimulation of 
glycogenesis in glycogen synthetase, and inhibiting the 
enzyme gluconeogenesis of glycogen phosphorylase 
[20], [21], [22], [23]. 
Weight loss can also be an indicator of 
improved insulin sensitivity and well-controlled glycemic. 
However, while there was weight loss in Group C at 
week 3, weight gain occurs in the control Groups A, B, 
C, and D induced by STZ-NA-HFD which could also 
be caused by the impaired insulin performance [22]. In 
DM, glycogen synthesis in rat liver and skeletal muscle 
is disrupted. The regulation of glycogen metabolism 
occurs by the enzymes glycogen synthase and glycogen 
phosphorylase that play a major role in glycogen 
metabolism. The decreasing of experimental muscle 
glycogen storage of diabetic rats has been associated 
with reduced glycogen synthase activity and increased 
glycogen phosphorylase activity [21]. Weight loss in 
Group C was caused by the poor insulin performance in 
which Group C had the highest average insulin resistance 
level of 5.87 ± 4.97. Therefore, there are indications 
of beta-cell damage resulting from hypoinsulinemia, 
hyperglycemia, and followed by excessive breakdown of 
muscle protein and fat to meet the energy requirements 
that are lacking due to the inadequacy of carbohydrates 
as an energy supplier. There was also a decrease in the 
rest of the extract treated groups with a value below the 
range of Group I [15], [24], [25], [26].
A glucose load test was performed to determine 
the body’s ability to use glucose as the main source [26]. 
In all groups in this study, the mean of BSL 30 min after 
loading was increased, reaching a peak at 1 h after 
loading and going back down at 1.5 h and 2 h after 
glucose loading. Groups that have a good ability to use 
glucose from 30 min to 2 h after loading were the group 
with metformin treatment, Group K while the group with 
the lowest mean of BSL was in Group I with a value 
of 115.75 ± 1.70 mg/dl. Even though metformin rapidly 
reduced the mean of BSL starting from 30 min, the 
effectiveness of hypoglycemia in 2 h after loading was 
not better when compared with Group I who received 
100 mg/kg b.w. ethyl acetate fractionation. The effects 
of hypoglycemia fractionation are caused by flavonoids, 
alkaloids, triterpene, glycosides, and saponins which 
result in the accumulation of glycogen through glycogen 
synthetase which is stimulated by insulin secretion [26].
Phytochemical in fruits and vegetables has 
an important role in reducing oxidative stress. The 
content of non-enzymatic antioxidants such as A, 
C, E, and enzymatic antioxidants such as SOD and 
CAT in fruits and vegetables is active compounds for 
reducing oxidative stress [27]. In this study, the highest 
enzymatic antioxidant SOD was in Group H treated 
with ethyl acetate 45 mg/kg b.w. Ethyl acetate fraction 
can increase SOD which acts as a first-line antioxidant 
that is able to withstand ROS. The SOD protects cells 
from ROS by reducing oxygen radicals, which damages 
membranes and biological structures. SOD can 
catalyze disposal oxygen radicals to H2O2 which then 
deactivated to H2O by CAT. The SOD can act as a major 
defense against ROS and prevent further production of 
free radicals. The SOD activity was found to be lower 
in diabetic subjects due to inactivation by H2O2 or by 
enzyme glycation, which occurs in diabetes. CAT is a 
protein heme, which is present in almost all mammalian 
cells and is responsible for reducing H2O2 to protect 
cells from highly reactive OH radicals. The reduced 
CAT activity can also be caused by inactivation by the 
glycation enzyme. Any combination with antioxidant 
properties can contribute to the reduction of partial or 
total oxidative damage. As a result, eliminating oxygen 
radicals and hydroxyl radicals are perhaps one of the 
most effective defenses against disease. This research 
shows that treatment with ethyl fraction 45 mg/kg 
b.w. can increase SOD activity as a compensatory 
mechanism against high oxidative stress precursors 
such as superoxide, hydroxyl radicals, and hydrogen 
peroxide, which are free radicals that are most often 
found in hyperglycemia conditions [27], [28].
Flavonoids have been proven to be good 
antioxidants in the treatment of oxidative stress induced 
by STZ [21]. Oxidative stress levels assessed by MDA 
markers were lower in the H group given ethyl acetate 
45 mg/kg b.w. This was due to the high antioxidant SOD 
that could reduce free radicals so that oxidative stress 
decreased in this group [27], [28].
Liver plays a role in regulating glucose 
homeostasis through insulin that regulates 
glucose homeostasis between incoming glucose 
(glucose uptake and glycogen synthesis) and 
glucose out (glycogenolysis and gluconeogenesis). 
Insulin mediates physiological processes through 
different mechanisms involving increasing levels of 
plasma membrane glucose transporter 4 (GLUT4); 
hexokinase stimulation and glycogen synthase kinase 
3 (GSK3); inhibition of glycogen phosphorylase; 
phosphoenolpyruvate carboxykinase (PEPCK); and 
glucose-6-phosphatase (G6Pase). The decrease in 
liver glycogen may be caused by the decrement of 
GLUT4 regulation, hexokinase, and GSK3 due to the 
absence of insulin [29]. In this research, the lowest 
insulin levels were in Group E which received ethanol 
extract 45 mg/kg b.w. with insulin levels 0.44 ± 0.24. 
Although insulin levels were low in Group E, insulin 
resistance was also low in 0.16 ± 0.08. The level of 
fasting BSL in the spectrophotometry showed mean 
levels of 155.16 ± 31.92. This situation shows that 
ethanol extract 45 mg/kg b.w. did not stimulate insulin 
but increases insulin sensitivity.
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Conclusion
Ethyl acetate fraction, even the lowest dose, 
was better in reducing the body weight of rat compared 
to ethyl fraction 100 mg/kg b.w. and 150 mg/kg b.w.; 
and even better than other treated and control groups. 
Ethanol extract 150 mg /kg b.w. was able to increase body 
weight better than ethanol 45 mg/kg b.w. nor 150 mg/kg 
b.w. nor with ethyl acetate fraction. Ethyl acetate fraction 
100 mg/kg b.w. was able to reduce BSL in 2 h loading 
better than other treatment groups. Ethyl acetate 
fraction 45 mg/kg b.w. could increase the endogenous 
antioxidant activity of SOD while reducing oxidative 
stress. Ethanol extract 45 mg/kg b.w. was unable to 
stimulate insulin secretion while having hypoglycemia 
capacity through the raise of insulin sensitivity. Ethanol 
extract 45 mg/ kg b.w. could decrease insulin sensitivity.
References
1. Sheikhpour R. Diabetes and oxidative stress: The mechanism 
and action. Iran J Diabetes Obes. 2013;5(1):40-5.
2. Ganjifrockwala FA, Joseph JT, George G. Decreased total 
antioxidant levels and increased oxidative stress in South 
African Type 2 diabetes mellitus patients. J Endocrinol Metab 
Diabetes South Afr. 2017;22(2):21-5. https://doi.org/10.1080/16
089677.2017.1324590
3. Tangvarasittichai S. Oxidative stress, insulin resistance, 
dyslipidemia and Type 2 diabetes mellitus. World J Diabetes. 
2015;6(3):456-80. https://doi.org/10.4239/wjd.v6.i3.456
 PMid:25897356
4. Holt RI. Diagnosis, epidemiology and pathogenesis of 
diabetes mellitus: An update for psychiatrists. Br J Psychiatry. 
2004;47:S55-63. https://doi.org/10.1192/bjp.184.47.s55
 PMid:15056594
5. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA 
modeling. Diabetes Care. 2004;27(6):1487-95. https://doi.
org/10.2337/diacare.27.6.1487
 PMid:15161807
6. Popa S, Mota M. Beta-cell Function and Failure in Type 2 
Diabetes. London, United Kingdom: IntechOpen; 2013.
7. Kaku K. Pathophysiology of Type 2 DM and its treatment policy. 
JMAJ. 2010;53(1):41-6.
8. Ozougwu JC, Obimba KC, Belonwu CD, Unakalamba CB. 
The pathogenesis and pathophysiology of Type 1 and Type 2 
diabetes mellitus. Acad J. 2013;4(4):46-57.
9. Stauffacher W, Burr I, Gutzeit A, Beaven D, Veleminsky J, 
Renold AE. Streptozotocin diabetes: Time course of irreversible 
B-cell damage; further observations on prevention by 
nicotinamide. Exp Biol Med. 1970;133(1):194-200. https://doi.
org/10.3181/00379727-133-34439
10. Szkudelski T. Streptozotocin-nicotinamide-induced diabetes in 
the rat. Characteristics of the experimental model. Exp Biol Med. 
2012;237(5):481-90. https://doi.org/10.1258/ebm.2012.011372
 PMid:22619373
11. Siahaan JM, Harahap U, Loesnihari R. Effect of ethanol extract 
of chayote (Sechium edule Jacq. Swartz) on the activity of 
glutathione peroxide (GPx) in house mice (Mus musculus L) 
strain DD webster hyperglycemia induced by streptozotocin 
(STZ). Indones J Med. 2016;1(1):44-9. https://doi.org/10.26911/
theijmed.2016.01.01.06
12. Siahaan, JM. Effect of antihipoglycemic Sechium edule 
Jacq. Swartz. Etanol extract on histopathologic changes in 
hyperglycemic Mus musculus L. Indones J Med. 2017;2(2):86-
93. https://doi.org/10.26911/theijmed.2017.02.02.02
13. Pari L, Karthikesan K, Menon VP. Comparative and combined 
effect of chlorogenic acid and tetrahydrocurcumin on antioxidant 
disparities in chemical induced experimental diabetes. Mol 
Cell Biochem. 2010;341(1-2):109-17. https://doi.org/10.1007/
s11010-010-0442-5
 PMid:20339905
14. Firdous SM, Singh A. Effect of Ipomoea staphylina leaves 
on streptozotocin-nicotinamide induced Type-II diabetes in 
Wistar. Asian Pac J Health Sci. 2016;3(3):30-44. https://doi.
org/10.21276/apjhs.2016.3.3.6
15. Listianasari Y, Dirgahayu P, Wasita B, Nuhriawangsa A, 
Magna P. Efektivitas pemberian jus labu siam (Sechium 
edule) terhadap profil lipid tikus (Rattus novergicus) model 
hiperlipidemia. Penelitian Gizi Makanan. 2017;40(1):35-43. 
https://doi.org/10.22435/pgm.v40i1.6046.35-43
16. Leite AC, Araujo TG, Carvalho BM, Maia MB, Lima VL. 
Characterization of the antidiabetic role of Parkinsonia aculeata 
(Caesalpineaceae). Evid Based Complement Alternat Med. 
2011;9:692378. https://doi.org/10.1155/2011/692378
17. Sornalakshmi V, Tresina SP, Paulpriya K, Packia LM, 
Mohan VR. Oral glucose tolerance test (OGTT) in normal 
control and glucose induced hyperglycemic rats with Hedyotis 
leschenaultiana DC. Int J Toxicol Pharmacol Res. 2016;8(1):59-
62. https://doi.org/10.1201/9780429487767-22
18. Sulaiman CT, Shahida V, Balachandran I. Effect of extraction 
solvent on the phytoconstituents of Aegle marmelos (L.) correa. 
J Natl Remedies. 2015;15(1):58-64. https://doi.org/10.18311/
jnr/2015/498
19. Olaokun OO, McGaw LJ, Rensburg IJ, Jacobus N, Eloff JN, 
Naidoo V. Antidiabetic activity of the ethyl acetate fraction of Ficus 
lutea (Moraceae) leaf extract: Comparison of an in vitro assay 
with an in vivo obese mouse model. BMC Complement Altern 
Med. 2016;16:110. https://doi.org/10.1186/s12906-016-1087-z
 PMid:27029351
20. Balasubramanian T, Chatterjee TK, Senthilkumar GP, Mani T. 
Effect of potent ethyl acetate fraction of Stereospermum 
suaveolens extract in streptozotocin-induced diabetic rats. 
ScientificWorldJournal. 2012;2012:413196. https://doi.
org/10.1100/2012/413196
 PMid:22593683
21. Kumarappan CT, Thilagam E, Vijayakumar M, Mandal SC. 
Modulatory effect of polyphenolic extracts of Ichnocarpus 
frutescens on oxidative stress in rats with experimentally 
induced diabetes. Indian J Med Res. 2012;136(5):815-21. 
https://doi.org/10.1016/j.sjbs.2012.04.004
 PMid:23287129
22. Verma N, Amresh G, Sahu PK, Rao CV, Singh AP. 
Antihyperglycemic and antihyperlipidemic activity of 
ethyl acetate fraction of Rhododendron arboreum smith 
flowers in streptozotocin induced diabetic rats and its 
role in regulating carbohydrate metabolism. Asian Pac J 
Trop Biomed. 2012;2(9):696-701. https://doi.org/10.1016/
s2221-1691(12)60212-3
 PMid:23569997
23. Okoduwa SI, Umar IA, James DB, Inuwa HM. Anti-diabetic 
potential of Ocimum gratissimum Leaf fractions in fortified 
diet-fed streptozotocin treated rat model of Type-2 diabetes. 
Medicines (Basel). 2017;4(4):73. https://doi.org/10.3390/
medicines4040073
 Siahaan et al. Ethanol and Ethyl Acetate Fraction of Chayote fruit (Sechium edule Jacq. Swartz) on the Oxidative Stress and Insulin Resistance
Open Access Maced J Med Sci. 2020 Dec 15; 8(A):962-969. 969
 PMid:29019956
24. Mousavi L, Mohd SR, Murugaiyah V, Asmawi MZ. Hypoglycemic 
and anti-hyperglycemic study of Ocimum tenuiflorum L. Leaves 
extract in normal and streptozotocin-induced diabetic rats. 
Asian Pac J Trop Biomed. 2016;6(12):1029-36. https://doi.
org/10.1016/j.apjtb.2016.10.002
25. Mhya DH, Anigo KM, Umar IA, Alegbejo JO. Evaluation 
of anti-hyperglycemic effect of sub-fractions derived from 
ethanol-aqueous fraction of Balanites aegyptiaca leaves 
in streptozotocin-induced diabetic rats. Asian J Biol Sci. 
2019;12(2):164-72. https://doi.org/10.3923/ajbs.2019.164.172
26. Hossain MS, Khan MR, Anisuzzaman AS, Ahmed M, Amran MS, 
Islam A. Antidiabetic and glycogenesis effects of different 
fractions of ethanolic extract of leaves of Mangifera indica 
(Linn.) in normal and alloxan induced diabetic rats. J Med Sci. 
2010;10:80-6. https://doi.org/10.3923/jms.2010.80.86
27. Aboonabi A, Rahmat A, Othman F. Antioxidant effect of 
pomegranate against streptozotocin-nicotinamide generated 
oxidative stress induced diabetic rats. Toxicol Rep. 2014;1:915-
22. https://doi.org/10.1016/j.toxrep.2014.10.022
 PMid:28962304
28. Ononamadu CJ, Alhassan AJ, Ibrahim A, Imam AA, 
Ihegboro GO, Owolarafe TA, et al. Methanol-extract/fractions 
of Dacryodes edulis Leaves ameliorate hyperglycemia and 
associated oxidative stress in streptozotocin-induced diabetic 
Winstar rats. J Evid Based Integr Med. 2019;24:1-12. https://
doi.org/10.1177/2515690x19843832
 PMid:31055945
29. Ubhenin B, Adamude FA, Dingwoke EJ, Nwobodo NN. 
Hypolipidamic study of ethyl acetate leaves extract of 
Momordica charantia on the biochemical parameters of 
streptozotocin-nicotinamide induced Type 2 diabetic rats. 
Biomed Res. 2019;30(4):201. https://doi.org/10.35841/
biomedicalresearch.30-19-201
